Authors:
VILVEN JC
DOMALEWSKI M
PROSSNITZ ER
YE RD
MUTHUKUMARASWAMY N
HARRIS RB
FREER RJ
SKLAR LA
Citation: Jc. Vilven et al., STRATEGIES FOR POSITIONING FLUORESCENT-PROBES AND CROSS-LINKERS ON FORMYL PEPTIDE LIGANDS, Journal of receptor and signal transduction research, 18(2-3), 1998, pp. 187-221
Citation: Cy. Anderson et al., C5AR LIGAND PEPTIDE 3D QSAR STUDY PERFORMED WITH AN APPLIED LINEAR CONFORMATION, The journal of peptide research, 49(6), 1997, pp. 476-483
Authors:
DOMALEWSKI MD
GUYER DA
FREER RJ
MUTHUKUMARASWAMY N
SKLAR LA
Citation: Md. Domalewski et al., FIXATION TRAPS FORMYL PEPTIDE RECEPTORS IN HIGH AND LOW-AFFINITY FORMS THAT CAN BE REGULATED BY GTP[S] IN THE ABSENCE OF LIGAND, Journal of receptor and signal transduction research, 16(1-2), 1996, pp. 59-75
Citation: C. Anderson et Rj. Freer, COMPARATIVE MOLECULAR-FIELD ANALYSIS OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE C5A RECEPTOR AGONIST PEPTIDES, The FASEB journal, 10(3), 1996, pp. 2231-2231
Authors:
FAY SP
HABBERSETT R
DOMALEWSKI MD
POSNER RG
HOUGHTON TG
PIERSON E
MUTHUKUMARASWAMY N
WHITAKER J
HAUGLAND RP
FREER RJ
SKLAR LA
Citation: Sp. Fay et al., MULTIPARAMETER FLOW CYTOMETRIC ANALYSIS OF A PH SENSITIVE FORMYL PEPTIDE WITH APPLICATION TO RECEPTOR STRUCTURE AND PROCESSING KINETICS, Cytometry, 15(2), 1994, pp. 148-153
Authors:
GAO JL
BECKER EL
FREER RJ
MUTHUKUMARASWAMY N
MURPHY PM
Citation: Jl. Gao et al., A HIGH POTENCY NONFORMYLATED PEPTIDE AGONIST FOR THE PHAGOCYTE N-FORMYLPEPTIDE CHEMOTACTIC RECEPTOR, The Journal of experimental medicine, 180(6), 1994, pp. 2191-2197